Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
about
Recent Treatments of Interstitial Lung Disease with Systemic SclerosisHuman pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension.Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studySerum amyloid A is a marker for pulmonary involvement in systemic sclerosis.A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisBaseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis.Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the University of California, San Diego, Shortness of Breath Questionnaire.Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis.Evaluation and management approaches for scleroderma lung disease.Right Ventricle Remodeling and Function in Scleroderma Patients.Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort.Systemic sclerosis-associated pulmonary arterial hypertension.
P2860
Q26773161-5D330701-8C76-42BB-8856-03509D68924DQ34430183-D1F59858-EB3C-4233-86E7-4308106EA4E4Q34987366-3B8D1461-A434-4D9B-AA89-BD24FE345117Q35064030-6B475EFB-E0EA-4C69-B441-BDB3F23908CFQ35096375-0A2A7B39-26BF-4233-B7F0-7B7E843AE91DQ36098875-72784434-C1BC-44AE-A12E-58030093C2FCQ36307583-616F2466-12A5-4372-A091-064F07BB0F11Q37200751-003B7E86-852D-437C-BEAE-0CDBAB22BB34Q37233050-CC67940E-526C-4032-9C19-CBB6FB088215Q38101137-5CE00E9A-B967-4D75-9D3C-5D698BE6A32CQ38135045-155CCBDA-17E1-4313-B702-DE036CCA75A6Q38630663-53320352-1C75-40B0-9741-5631E998B64EQ40578596-1B93115E-50C7-4C94-AAB4-F5CE1B744453Q42475025-7166C6BF-30C2-477E-8FB1-EB3E3EA8230DQ43838317-D6F617CD-31CF-4C7F-A545-DF27601F6D00Q44149105-AB53E654-14BC-46A4-94E4-63AE5FABB58BQ48148896-D9AC657A-615E-47FC-8EFF-B60723713777Q50052795-58F8441D-E761-467D-8F4F-CA0FE1A8DA03Q52939870-13F1CDBD-E781-414C-A640-D446710E3380Q55153213-6307599D-AA57-4D3D-9AA7-342FE7E441E1Q55230002-C1F94FE3-A048-4DD4-A8D6-06C9B2A41816Q55309547-0CB74406-5515-4396-BF4F-ED69D4D8C872
P2860
Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pulmonary Hypertension Assessm ...... scription of study population.
@ast
Pulmonary Hypertension Assessm ...... scription of study population.
@en
type
label
Pulmonary Hypertension Assessm ...... scription of study population.
@ast
Pulmonary Hypertension Assessm ...... scription of study population.
@en
prefLabel
Pulmonary Hypertension Assessm ...... scription of study population.
@ast
Pulmonary Hypertension Assessm ...... scription of study population.
@en
P2093
P2860
P356
P1476
Pulmonary Hypertension Assessm ...... scription of study population.
@en
P2093
Aryeh Fischer
Elena Schiopu
Monique Hinchcliff
PHAROS Investigators
Virginia D Steen
P2860
P304
P356
10.3899/JRHEUM.101243
P407
P577
2011-08-15T00:00:00Z